Related references
Note: Only part of the references are listed.Polypharmacy and Drug-Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study
Beatriz Lopez-Centeno et al.
CLINICAL INFECTIOUS DISEASES (2020)
Deprescribing of non-antiretroviral therapy in HIV-infected patients
Jose-Ramon Blanco et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
The challenge of HIV treatment in an era of polypharmacy
David Back et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2020)
Interactions between antiretroviral therapy and complementary and alternative medicine: a narrative review
C. Bordes et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety
Kimberly K. Scarsi et al.
DRUGS (2020)
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0
L. Ryom et al.
HIV MEDICINE (2020)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2020 Recommendations of the International Antiviral Society-USA Panel
Michael S. Saag et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Evolution of Drug Interactions With Antiretroviral Medication in People With HIV
Majdouline El Moussaoui et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Risk and Cost Associated With Drug-Drug Interactions Among Aging HIV Patients Receiving Combined Antiretroviral Therapy in France
Ludivine Demessine et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Cushing's syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case-control study in the French Pharmacovigilance Database
Laure Peyro-Saint-Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
Perrine Courlet et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Ageing with HIV: do comorbidities and polymedication drive treatment optimization?
L. Cuzin et al.
HIV MEDICINE (2017)
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study (vol 72, pg 2879, 2017)
Silvia Nozza et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario
Claire E. Kendall et al.
BMC PUBLIC HEALTH (2014)
Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
Judith Schouten et al.
CLINICAL INFECTIOUS DISEASES (2014)
Polypharmacy, Drug Drug Interactions, and Potentially Inappropriate Medications in Older Adults with Human Immunodeficiency Virus Infection
Meredith Greene et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
Danijela Gnjidic et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study
Barbara Hasse et al.
CLINICAL INFECTIOUS DISEASES (2011)
Use/misuse of over-the-counter medications and associated adverse drug events among HIV-infected patients
Elizabeth Ajuoga et al.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2008)
Share Paper
